Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

CNS 1

Conditions

Melanoma 5Glioma 5Glioblastoma 5Neoplasm Metastasis 3Uterine Cervical Dysplasia 2Keratosis, Actinic 2Ependymoma 2Breast Neoplasms 2Brain Neoplasms 2Astrocytoma 2Uterine Cervical Neoplasms 1Urinary Bladder Neoplasms 1Stomach Neoplasms 1Sialorrhea 1Sarcoma 1Precancerous Conditions 1Non-Muscle Invasive Bladder Neoplasms 1Neurofibromatosis 1 1Medulloblastoma 1Diffuse Intrinsic Pontine Glioma 1Colorectal Neoplasms 1Carcinoma, Basal Cell 1Bone Neoplasms 1Atypical Squamous Cells of the Cervix 1Adenocarcinoma 1

Interventions

Deoxycholic Acid 4AZD 6244 4Polidocanol 2Lasers, Solid-State 2talimogene laherparepvec 1pomalidomide 1pirfenidone 1lorlatinib 1encorafenib 1diphenylcyclopropenone 1cabozantinib 1binimetinib 1X-Rays 1Vinblastine 1Specimen Handling 1Sorafenib 1Photons 1Pharmacokinetics 1Magnetic Resonance Spectroscopy 1Lovastatin 1Lasers 1Imiquimod 1High-Energy Shock Waves 1Curcumin 1Cetuximab 1Carboplatin 1Biopsy 1Acetaminophen 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 1 × Neurofibromatosis 1 × Imiquimod × Clear all
NCT00865644 2017-01-10

Topical Imiquimod 5% Cream for Treatment of Cutaneous Neurofibromas in Adults With Neurofibromatosis 1

Massachusetts General Hospital

Phase 1 Completed
11 enrolled
CNS

Neurofibromatosis 1

Data powered by HemOnc (CC BY 4.0) Colophon âš¡